261 related articles for article (PubMed ID: 12024039)
1. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.
MacLachlan TK; Takimoto R; El-Deiry WS
Mol Cell Biol; 2002 Jun; 22(12):4280-92. PubMed ID: 12024039
[TBL] [Abstract][Full Text] [Related]
2. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
3. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
4. Repression of BRCA1 through a feedback loop involving p53.
MacLachlan TK; Dash BC; Dicker DT; El-Deiry WS
J Biol Chem; 2000 Oct; 275(41):31869-75. PubMed ID: 10884389
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor p53 is required to modulate BRCA1 expression.
Arizti P; Fang L; Park I; Yin Y; Solomon E; Ouchi T; Aaronson SA; Lee SW
Mol Cell Biol; 2000 Oct; 20(20):7450-9. PubMed ID: 11003642
[TBL] [Abstract][Full Text] [Related]
6. E2F1 regulates p53R2 gene expression in p53-deficient cells.
Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
[TBL] [Abstract][Full Text] [Related]
7. A ribonucleotide reductase gene is a transcriptional target of p53 and p73.
Nakano K; Bálint E; Ashcroft M; Vousden KH
Oncogene; 2000 Aug; 19(37):4283-9. PubMed ID: 10980602
[TBL] [Abstract][Full Text] [Related]
8. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
[TBL] [Abstract][Full Text] [Related]
9. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
10. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
11. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.
Fabbro M; Savage K; Hobson K; Deans AJ; Powell SN; McArthur GA; Khanna KK
J Biol Chem; 2004 Jul; 279(30):31251-8. PubMed ID: 15159397
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner.
Zhang W; Luo J; Chen F; Yang F; Song W; Zhu A; Guan X
Oncotarget; 2015 Apr; 6(10):7608-18. PubMed ID: 25797244
[TBL] [Abstract][Full Text] [Related]
13. p53 suppresses hyper-recombination by modulating BRCA1 function.
Dong C; Zhang F; Luo Y; Wang H; Zhao X; Guo G; Powell SN; Feng Z
DNA Repair (Amst); 2015 Sep; 33():60-9. PubMed ID: 26162908
[TBL] [Abstract][Full Text] [Related]
14. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of repair genes by BRCA1.
El-Deiry WS
Cancer Biol Ther; 2002; 1(5):490-1. PubMed ID: 12496474
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and p53 regulate critical prostate cancer pathways.
De Luca P; Moiola CP; Zalazar F; Gardner K; Vazquez ES; De Siervi A
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):233-8. PubMed ID: 23670255
[TBL] [Abstract][Full Text] [Related]
17. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex.
Fischer JL; Lancia JK; Mathur A; Smith ML
Anticancer Res; 2006; 26(2A):899-904. PubMed ID: 16619485
[TBL] [Abstract][Full Text] [Related]
18. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest.
Ongusaha PP; Ouchi T; Kim KT; Nytko E; Kwak JC; Duda RB; Deng CX; Lee SW
Oncogene; 2003 Jun; 22(24):3749-58. PubMed ID: 12802282
[TBL] [Abstract][Full Text] [Related]
20. Repression of new p53 targets revealed by ChIP on chip experiments.
Ceribelli M; Alcalay M; Viganò MA; Mantovani R
Cell Cycle; 2006 May; 5(10):1102-10. PubMed ID: 16721047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
